Page last updated: 2024-11-06

thymidine and Leukemia, Myelomonocytic, Juvenile

thymidine has been researched along with Leukemia, Myelomonocytic, Juvenile in 1 studies

Leukemia, Myelomonocytic, Juvenile: A leukemia affecting young children characterized by SPLENOMEGALY, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, M1
Takahashi, Y1
Xu, Y1
Yoshida, N1
Yoshimi, A1
Villalobos, IB1
Hama, A1
Nishio, N1
Hidaka, H1
Wang, Y1
Yagasaki, H1
Kojima, S1

Other Studies

1 other study available for thymidine and Leukemia, Myelomonocytic, Juvenile

ArticleYear
Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.
    Leukemia research, 2008, Volume: 32, Issue:7

    Topics: Cell Proliferation; Child, Preschool; Female; Genes, ras; Granulocyte-Macrophage Colony-Stimulating

2008